Drug Approval | June 12, 2024
IOL Chemicals receives EDQM CEP certificate for Pantoprazole Sodium Sesquihydrate and Allopurinol
EDQM has also issued a Certificate of Suitability for Allopurino
EDQM has also issued a Certificate of Suitability for Allopurino
Vonoprozan is a novel potassium-competitive acid blocker used for the treatment of acid related disorders
Merck shared updates on the company’s oncology pipeline and focused R&D approach
Strides’ approval for this product marks the 1st Indian approval from the USFDA for this complex formulation
The approval of YESAFILI marks Biocon Biologics’ expansion into the ophthalmology therapeutic area in the United States
If approved, the Opdivo-based regimen would be the first immunotherapy-chemotherapy combination approved for this patient population in the EU
For the first-line treatment of certain patients with metastatic non-small cell lung cancer
Liraglutide is a drug-device combination formulation used in the treatment of Type 2 Diabetes Mellitus
Both organisations enter into a long- term collaboration to expand patient access in India
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
